206 related articles for article (PubMed ID: 20621521)
1. Cerebral infarction in Duchenne muscular dystrophy.
Tsakadze N; Katzin LW; Krishnan S; Behrouz R
J Stroke Cerebrovasc Dis; 2011; 20(3):264-5. PubMed ID: 20621521
[TBL] [Abstract][Full Text] [Related]
2. Intracardiac thrombus and cerebral infarction in a patient with duchenne muscular dystrophy.
Gimenez-Muñoz A; Capablo JL; Alarcia R; Torné L; Errea JM
J Clin Neuromuscul Dis; 2009 Dec; 11(2):79-80. PubMed ID: 19955989
[No Abstract] [Full Text] [Related]
3. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy.
Viollet L; Thrush PT; Flanigan KM; Mendell JR; Allen HD
Am J Cardiol; 2012 Jul; 110(1):98-102. PubMed ID: 22463839
[TBL] [Abstract][Full Text] [Related]
4. [Repeated cerebral infarction in a patient with Duchenne's muscular dystrophy].
Díaz Buschmann C; Ruiz Falcó ML; Tamariz Martel Moreno A; García Peñas JJ; Gutiérrez Solana LG; Pérez Jiménez A; Marín C
Rev Neurol; 2004 Mar 16-31; 38(6):533-6. PubMed ID: 15054717
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy.
Fayssoil A
Indian Heart J; 2010; 62(3):273. PubMed ID: 21275309
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy.
Finsterer J; Stöllberger C
Neuromuscul Disord; 2009 Jan; 19(1):74; author reply 75. PubMed ID: 19070488
[No Abstract] [Full Text] [Related]
7. Treatment of the heart in Duchenne muscular dystrophy.
Baxter P
Dev Med Child Neurol; 2006 Mar; 48(3):163. PubMed ID: 16483388
[No Abstract] [Full Text] [Related]
8. [Management of myocardial damage in muscular dystrophy].
Tamura T
Brain Nerve; 2011 Nov; 63(11):1217-28. PubMed ID: 22068474
[TBL] [Abstract][Full Text] [Related]
9. Cardiac management of ventilator-assisted individuals with Duchenne muscular dystrophy.
O'Brien L; Varadi R; Goldstein RS; Evans RA
Chron Respir Dis; 2014 May; 11(2):103-10. PubMed ID: 24728656
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
Spurney CF
Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy.
Ogata H; Ishikawa Y; Ishikawa Y; Minami R
J Cardiol; 2009 Feb; 53(1):72-8. PubMed ID: 19167641
[TBL] [Abstract][Full Text] [Related]
13. [Cardiologic study of 10 patients with Duchenne muscular dystrophy(DMD): personal experience].
Falsaperla R; Romeo G; Sciacca P; Di Giorgio A; Mattia CL; Distefano G
Pediatr Med Chir; 2001; 23(1):57-60. PubMed ID: 11486424
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of Duchenne muscular dystrophy complicated with dilated cardiomyopathy and cerebral infarction].
Ikeniwa C; Sakai M; Kimura S; Wakayama T; Kuru S; Yasuma F; Konagaya M
No To Shinkei; 2006 Mar; 58(3):250-5. PubMed ID: 16629452
[TBL] [Abstract][Full Text] [Related]
15. Duchenne muscular dystrophy: how bad is the heart?
McNally EM
Heart; 2008 Aug; 94(8):976-7. PubMed ID: 18625791
[No Abstract] [Full Text] [Related]
16. Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.
Bourke JP; Watson G; Muntoni F; Spinty S; Roper H; Guglieri M; Speed C; McColl E; Chikermane A; Jayawant S; Adwani S; Willis T; Wilkinson J; Bryant A; Chadwick T; Wood R; Bushby K;
BMJ Open; 2018 Dec; 8(12):e022572. PubMed ID: 30573480
[TBL] [Abstract][Full Text] [Related]
17. New approaches in the therapy of cardiomyopathy in muscular dystrophy.
McNally EM
Annu Rev Med; 2007; 58():75-88. PubMed ID: 17217326
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy.
Fayssoil A; Abasse S; Silverston K
J Neuromuscul Dis; 2017; 4(1):17-23. PubMed ID: 28269790
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.
Fayssoil A; Nardi O; Orlikowski D; Annane D
Heart Fail Rev; 2010 Jan; 15(1):103-7. PubMed ID: 19943106
[TBL] [Abstract][Full Text] [Related]
20. Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.
Silva MC; Magalhães TA; Meira ZM; Rassi CH; Andrade AC; Gutierrez PS; Azevedo CF; Gurgel-Giannetti J; Vainzof M; Zatz M; Kalil-Filho R; Rochitte CE
JAMA Cardiol; 2017 Feb; 2(2):190-199. PubMed ID: 27926769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
